Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

VRN11

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Voronoi

Drug class:

EGFR C797S inhibitor

Related drugs:

‹

›

EGFR L858R	Non Small Cell Lung Cancer	EGFR L858R	Non Small Cell Lung Cancer	VRN11 Sensitive: D – Preclinical VRN11 Sensitive : D	VRN11 Sensitive: D – Preclinical VRN11 Sensitive : D
EGFR exon 19 deletion	Non Small Cell Lung Cancer	EGFR exon 19 deletion	Non Small Cell Lung Cancer	VRN11 Sensitive: D – Preclinical VRN11 Sensitive : D	VRN11 Sensitive: D – Preclinical VRN11 Sensitive : D
EGFR L858R + EGFR C797S	Non Small Cell Lung Cancer	EGFR L858R + EGFR C797S	Non Small Cell Lung Cancer	VRN11 Sensitive: D – Preclinical VRN11 Sensitive : D	VRN11 Sensitive: D – Preclinical VRN11 Sensitive : D
EGFR exon 19 deletion + EGFR C797S	Non Small Cell Lung Cancer	EGFR exon 19 deletion + EGFR C797S	Non Small Cell Lung Cancer	VRN11 Sensitive: D – Preclinical VRN11 Sensitive : D	VRN11 Sensitive: D – Preclinical VRN11 Sensitive : D